Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 3 studies | 17% ± 1% | |
GABAergic neuron | 3 studies | 23% ± 5% | |
oligodendrocyte | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3023.71 | 1445 / 1445 | 100% | 30.90 | 183 / 183 |
lung | 100% | 3527.26 | 578 / 578 | 100% | 50.07 | 1154 / 1155 |
breast | 100% | 2602.36 | 459 / 459 | 100% | 62.12 | 1116 / 1118 |
prostate | 100% | 3053.42 | 245 / 245 | 100% | 51.56 | 501 / 502 |
bladder | 100% | 3423.86 | 21 / 21 | 100% | 53.70 | 502 / 504 |
uterus | 100% | 2295.44 | 170 / 170 | 100% | 53.76 | 457 / 459 |
thymus | 100% | 2027.22 | 652 / 653 | 100% | 36.62 | 603 / 605 |
skin | 100% | 3800.07 | 1809 / 1809 | 99% | 43.27 | 468 / 472 |
stomach | 99% | 1878.04 | 357 / 359 | 100% | 31.59 | 285 / 286 |
intestine | 100% | 4014.97 | 966 / 966 | 99% | 33.88 | 521 / 527 |
kidney | 100% | 1727.66 | 89 / 89 | 98% | 33.42 | 886 / 901 |
brain | 98% | 1419.21 | 2596 / 2642 | 100% | 54.35 | 705 / 705 |
ovary | 100% | 2016.51 | 180 / 180 | 98% | 26.93 | 421 / 430 |
adrenal gland | 99% | 1871.95 | 256 / 258 | 95% | 24.91 | 219 / 230 |
pancreas | 92% | 867.45 | 302 / 328 | 98% | 40.33 | 175 / 178 |
liver | 96% | 926.35 | 218 / 226 | 89% | 18.45 | 361 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 99.80 | 29 / 29 |
spleen | 100% | 3883.96 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 61.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 52.73 | 1 / 1 |
blood vessel | 100% | 2007.17 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2239.28 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 4614.74 | 924 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 22.06 | 79 / 80 |
heart | 97% | 1687.84 | 832 / 861 | 0% | 0 | 0 / 0 |
muscle | 94% | 938.69 | 754 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_0005739 | Cellular component | mitochondrion |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TRAFD1 |
Protein name | TRAF-type zinc finger domain-containing protein 1 (Protein FLN29) Alternative protein TRAFD1 TRAF-type zinc finger domain containing 1 TRAF-type zinc finger domain-containing protein 1 |
Synonyms | FLN29 |
Description | FUNCTION: Negative feedback regulator that controls excessive innate immune responses. Regulates both Toll-like receptor 4 (TLR4) and DDX58/RIG1-like helicases (RLH) pathways. May inhibit the LTR pathway by direct interaction with TRAF6 and attenuation of NF-kappa-B activation. May negatively regulate the RLH pathway downstream from MAVS and upstream of NF-kappa-B and IRF3 (By similarity). . FUNCTION: Negative feedback regulator that controls excessive innate immune responses. Regulates both Toll-like receptor 4 (TLR4) and DDX58/RIG1-like helicases (RLH) pathways. May inhibit the LTR pathway by direct interaction with TRAF6 and attenuation of NF-kappa-B activation. May negatively regulate the RLH pathway downstream from MAVS and upstream of NF-kappa-B and IRF3. . FUNCTION: Negative feedback regulator that controls excessive innate immune responses. Regulates both Toll-like receptor 4 (TLR4) and DDX58/RIG1-like helicases (RLH) pathways. May inhibit the LTR pathway by direct interaction with TRAF6 and attenuation of NF-kappa-B activation. May negatively regulate the RLH pathway downstream from MAVS and upstream of NF-kappa-B and IRF3. . |
Accessions | ENST00000257604.9 [O14545-1] F8VVF3 ENST00000552890.5 [O14545-2] ENST00000549358.5 O14545 L8E7W3 S4R2Z9 ENST00000548092.5 F8VNX8 F8VWK2 ENST00000412615.7 [O14545-1] ENST00000547063.5 ENST00000552896.1 |